Results 41 to 50 of about 51,236 (315)

Succinate dehydrogenase (SDH)-deficient renal carcinoma:a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients [PDF]

open access: yes, 2014
Succinate dehydrogenase (SDH)-deficient renal carcinoma has been accepted as a provisional entity in the 2013 International Society of Urological Pathology Vancouver Classification.
Belinsky   +46 more
core   +3 more sources

Epidemiology of Pheochromocytoma and Paraganglioma: Population-based Cohort Study.

open access: yesEuropean Journal of Endocrinology, 2020
OBJECTIVE Despite the significant morbidity and mortality associated with pheochromocytoma and paraganglioma, little is known about their epidemiology.
A. Leung   +7 more
semanticscholar   +1 more source

Analysis of short-term blood pressure variability in pheochromocytoma/paraganglioma patients [PDF]

open access: yes, 2019
Data on short-term blood pressure variability (BPV), which is a well-established cardiovascular prognostic tool, in pheochromocytoma and paraganglioma (PPGL) patients is still lack and conflicting.
Bisogni, V.   +14 more
core   +1 more source

Preoperative Management of Pheochromocytoma and Paraganglioma

open access: yesFrontiers in Endocrinology, 2020
Pheochromocytoma and paraganglioma (PPGL) are rare neuroendocrine tumors, characterized by excessive release of catecholamines (CAs), and manifested as the classic triad of headaches, palpitations, profuse sweating, and a variety of other signs and ...
Fang Fang, Li Ding, Qing He, Ming Liu
semanticscholar   +1 more source

Magnetic resonance and computed tomography imaging of a carotid body tumor in a dog [PDF]

open access: yes, 2012
A 5-year-old castrated male Labrador Retriever was presented to a referring veterinarian for a swelling in the neck region. Based on the results of histopathology, a carotid body tumor, was diagnosed.
De Cock, Hilde   +4 more
core   +2 more sources

Oncometabolites: tailoring our genes [PDF]

open access: yes, 2015
Increased glucose metabolism in cancer cells is a phenomenon that has been known for over 90 years, allowing maximal cell growth through faster ATP production and redistribution of carbons towards nucleotide, protein and fatty acid synthesis.
Avril N, Buck AC, Gimm O, Higashi K
core   +1 more source

Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study.

open access: yesJournal of Clinical Endocrinology and Metabolism, 2019
BACKGROUND Malignant pheochromocytoma and paraganglioma (MPP) are characterized by prognostic heterogeneity. Our objective was to look for prognostic parameters of overall survival (OS) in MPP patients.
S. Hescot   +31 more
semanticscholar   +1 more source

Paraganglioma [PDF]

open access: yesJournal of the Endocrine Society, 2021
Abstract Introduction: Paragangliomas are rare neuroendocrine tumors arising from extra-adrenal medullary neural crest derivatives. The terms pheochromocytoma and paraganglioma are often used interchangeably because morphologically and functionally these entities are almost the same.
Aluko, Oluwatomisin A, Ruby, Edward
openaire   +1 more source

Fine needle aspiration cytology of hepatic metastases of neuroendocrine tumors: A 20‐year retrospective, single institutional study [PDF]

open access: yes, 2017
Background Fine needle aspiration (FNA) is considered an excellent technique for documenting metastatic neuroendocrine tumors (NETs). This study aims to evaluate the accuracy of FNA in diagnosing metastatic NETs to the liver and determining the grade ...
Cramer, Harvey   +3 more
core   +1 more source

Post-Transcriptional Dysregulation by miRNAs Is Implicated in the Pathogenesis of Gastrointestinal Stromal Tumor [GIST] [PDF]

open access: yes, 2013
peer-reviewedIn contrast to adult mutant gastrointestinal stromal tumors [GISTs], pediatric/wild-type GISTs remain poorly understood overall, given their lack of oncogenic activating tyrosine kinase mutations.
Hans-Ulrich Schildhaus   +12 more
core   +5 more sources

Home - About - Disclaimer - Privacy